Exponent (NASDAQ:EXPO) PT Raised to $100.00 at Truist Financial

Exponent (NASDAQ:EXPO) had its price objective raised by Truist Financial from $95.00 to $100.00 in a research note published on Monday morning, Benzinga reports. Truist Financial currently has a buy rating on the business services provider’s stock.

Separately, StockNews.com raised shares of Exponent from a sell rating to a hold rating in a report on Monday, March 4th.

Exponent Price Performance

Shares of EXPO opened at $93.20 on Monday. Exponent has a 1 year low of $64.61 and a 1 year high of $102.72. The company has a 50 day simple moving average of $80.23 and a two-hundred day simple moving average of $81.85. The firm has a market cap of $4.72 billion, a P/E ratio of 47.07 and a beta of 0.68.

Exponent (NASDAQ:EXPO) last posted its earnings results on Thursday, April 25th. The business services provider reported $0.59 earnings per share for the quarter, beating analysts’ consensus estimates of $0.46 by $0.13. Exponent had a net margin of 18.72% and a return on equity of 28.13%. The firm had revenue of $137.21 million during the quarter, compared to analyst estimates of $125.98 million. During the same period last year, the firm posted $0.56 earnings per share. Exponent’s revenue for the quarter was up 6.6% compared to the same quarter last year. On average, sell-side analysts anticipate that Exponent will post 1.76 earnings per share for the current year.

Exponent Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, June 21st. Investors of record on Friday, June 7th will be given a $0.28 dividend. The ex-dividend date is Friday, June 7th. This represents a $1.12 dividend on an annualized basis and a yield of 1.20%. Exponent’s dividend payout ratio is presently 56.57%.

Insider Buying and Selling

In related news, insider Eric Guyer sold 3,367 shares of the firm’s stock in a transaction on Friday, February 9th. The stock was sold at an average price of $78.49, for a total value of $264,275.83. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 2.20% of the stock is owned by corporate insiders.

Institutional Trading of Exponent

A number of institutional investors have recently bought and sold shares of the stock. Operose Advisors LLC bought a new stake in shares of Exponent during the third quarter worth $39,000. Benjamin F. Edwards & Company Inc. lifted its position in shares of Exponent by 866.0% during the first quarter. Benjamin F. Edwards & Company Inc. now owns 512 shares of the business services provider’s stock worth $42,000 after purchasing an additional 459 shares during the last quarter. Janiczek Wealth Management LLC lifted its position in shares of Exponent by 293.7% during the first quarter. Janiczek Wealth Management LLC now owns 626 shares of the business services provider’s stock worth $52,000 after purchasing an additional 467 shares during the last quarter. Principal Securities Inc. bought a new stake in shares of Exponent during the fourth quarter worth $69,000. Finally, YHB Investment Advisors Inc. bought a new stake in shares of Exponent during the first quarter worth $75,000. 92.37% of the stock is currently owned by institutional investors.

About Exponent

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.